Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes? (Q34631033)

3 August 2017

title

Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes? (English)

1 reference

3 August 2017

0 references

0 references

1 reference

3

Henry Völzke

0 references

Henri Wallaschofski

2

object named as

Henri Wallaschofski

0 references

Robin Haring

object named as

Robin Haring

6

0 references

Matthias Nauck

4

object named as

Matthias Nauck

1 reference

3 August 2017

Lisa Balbach

1

1 reference

3 August 2017

Marcus Dörr

5

1 reference

3 August 2017

publication date

21 March 2013

1 reference

3 August 2017

published in

BMC Endocrine Disorders

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

page(s)

12

1 reference

Metabolic syndrome: definition and therapeutic implications

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Potential role of prolactin in antipsychotic‐mediated association of schizophrenia and type 2 diabetes

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

The association of serum prolactin concentration with inflammatory biomarkers - cross-sectional findings from the population-based Study of Health in Pomerania

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Association of plasma aldosterone with the metabolic syndrome in two German populations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Insulin action in hyperthyroidism: a focus on muscle and adipose tissue

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Prolactin supplementation to culture medium improves beta-cell survival.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Immunomodulatory role of prolactin in diabetes development

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

beta-Cell specific cytoprotection by prolactin on human islets

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Adipocyte prolactin: regulation of release and putative functions.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Methods for improving regression analysis for skewed continuous or counted responses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Focus on prolactin as a metabolic hormone.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Prolactin Pulsatile Characteristics in Postmenopausal Women1

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Basal serum prolactin levels in obesity--unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Extended recruitment efforts minimize attrition but not necessarily bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Inverse association between total testosterone concentrations, incident hypertension and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Studies of insulin resistance in patients with clinical and subclinical hyperthyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Causation and causal inference in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Cohort Profile: The Study of Health in Pomerania

26 October 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Sex-specific associations of serum prolactin concentrations with cardiac remodeling: Longitudinal results from the Study of Health Pomerania (SHIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/1472-6823-13-12

Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3614874

Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining

9 December 2018

1 reference

12 December 2020

BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists

1 reference

12 December 2020

Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy

1 reference

12 December 2020

The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy

1 reference

12 December 2020

Prolactin levels independently predict major cardiovascular events in patients with erectile dysfunction

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6823-13-12

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference